Similarly, a multi-institutional study of 412 ICC patients revealed the most common genetic aberrations to be observed in TP53 (27%), CDK2NA/B (27%), KRAS (22%), ARID1A (18%), and IDH1 (16%) [27]. Here, KRAS is linked to intrahepatic cholangiocarcinoma.